Top

Published in:

01-07-2008 | Case Report

Successful Use of Bivalirudin for Superior Vena Cava Recanalization and Stent Placement in a Child with Heparin-Induced Thrombocytopenia

Authors: John P. Breinholt, Brady S. Moffett, Karen M. Texter, Frank F. Ing

Published in: Pediatric Cardiology | Issue 4/2008

Abstract

Heparin-induced thrombocytopenia (HIT) is a potentially life-threatening, adverse effect of heparin therapy. Patients with this complication require an alternative approach to anticoagulation. Bivalirudin is a direct thrombin inhibitor with an efficacy comparable to that of heparin, a short half-life, and reduced bleeding complications in adults. We present the case of a 2-year-old boy with HIT Type II who underwent recanalization of an occluded superior vena cava and stent placement, utilizing bivalirudin as anticoagulant.

Almond CS, Harrington J, Thiagarajan R et al (2006) Successful use of bivalirudin for cardiac transplantation in a child with heparin-induced thrombocytopenia. J Heart Lung Transplant 25:1376–1379PubMedCrossRef

Arepally GM, Ortel TL (2006) Clinical practice. Heparin-induced thrombocytopenia. N Engl J Med 355:809–817CrossRef

Chew DP, Lincoff AM, Gurm H et al (2005) Bivalirudin versus heparin and glycoprotein IIb/IIIa inhibition among patients with renal impairment undergoing percutaneous coronary intervention (a subanalysis of the REPLACE-2 trial). Am J Cardiol 95:581–585PubMedCrossRef

Freed MD, Keane JF, Rosenthal A (1974) The use of heparinization to prevent arterial thrombosis after percutaneous cardiac catheterization in children. Circulation 50:565–569PubMed

Girolami B, Prandoni P, Stefani PM et al (2003) The incidence of heparin-induced thrombocytopenia in hospitalized medical patients treated with subcutaneous unfractionated heparin: a prospective cohort study. Blood 101:2955–2959PubMedCrossRef

Huebler M, Koster A, Buz S et al (2006) Cardiopulmonary bypass for complex cardiac surgery using bivalirudin anticoagulation in a patient with heparin antibodies. J Card Surg 21:286–288PubMedCrossRef

Katzen BT, Ardid MI, MacLean AA et al (2005) Bivalirudin as an anticoagulation agent: safety and efficacy in peripheral interventions. J Vasc Interv Radiol 16:1183–1187, quiz 7PubMed

Koster A, Dyke CM, Aldea G et al (2007) Bivalirudin during cardiopulmonary bypass in patients with previous or acute heparin-induced thrombocytopenia and heparin antibodies: results of the CHOOSE-ON trial. Ann Thorac Surg 83:572–577PubMedCrossRef

Koster A, Spiess B, Chew DP et al (2004) Effectiveness of bivalirudin as a replacement for heparin during cardiopulmonary bypass in patients undergoing coronary artery bypass grafting. Am J Cardiol 93:356–359PubMedCrossRef

10.

Koster A, Spiess B, Jurmann M et al (2006) Bivalirudin provides rapid, effective, and reliable anticoagulation during off-pump coronary revascularization: results of the “EVOLUTION OFF” trial. Anesth Analg 103:540–544PubMedCrossRef

11.

Koster A, Weng Y, Bottcher W, Gromann T, Kuppe H, Hetzer R (2007) Successful use of bivalirudin as anticoagulant for ECMO in a patient with acute HIT. Ann Thorac Surg 83:1865–1967PubMedCrossRef

12.

Lincoff AM, Bittl JA, Harrington RA et al (2003) Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial. JAMA 289:853–863PubMedCrossRef

13.

Lincoff AM, Kleiman NS, Kereiakes DJ et al (2004) Long-term efficacy of bivalirudin and provisional glycoprotein IIb/IIIa blockade vs heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary revascularization: REPLACE-2 randomized trial. JAMA 292:696–703PubMedCrossRef

14.

Murphy GS, Marymont JH (2007) Alternative anticoagulation management strategies for the patient with heparin-induced thrombocytopenia undergoing cardiac surgery. J Cardiothorac Vasc Anesth 21:113–126PubMedCrossRef

15.

Pappalardo F, Franco A, Crescenzi G, Poli A, Zangrillo A, Koster A (2007) Successful use of bivalirudin for cardiopulmonary bypass in a patient with heparin allergy. Perfusion 22:67–69PubMedCrossRef

16.

Ranze O, Ranze P, Magnani HN, Greinacher A (1999) Heparin-induced thrombocytopenia in paediatric patients–a review of the literature and a new case treated with danaparoid sodium. Eur J Pediatr 158(Suppl 3):S130–S133PubMedCrossRef

17.

Risch L, Huber AR, Schmugge M (2006) Diagnosis and treatment of heparin-induced thrombocytopenia in neonates and children. Thromb Res 118:123–135PubMedCrossRef

18.

Seybert AL, Coons JC, Zerumsky K (2006) Treatment of heparin-induced thrombocytopenia: is there a role for bivalirudin? Pharmacotherapy 26:229–241PubMedCrossRef

19.

Shammas NW, Allie D, Hall P et al (2005) Predictors of in-hospital and 30-day complications of peripheral vascular interventions using bivalirudin as the primary anticoagulant: results from the APPROVE Registry. J Invasive Cardiol 17:356–359PubMed

20.

Shammas NW, Lemke JH, Dippel EJ et al (2003) Bivalirudin in peripheral vascular interventions: a single center experience. J Invasive Cardiol 15:401–404PubMed

21.

Stone GW, White HD, Ohman EM et al (2007) Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a subgroup analysis from the Acute Catheterization and Urgent Intervention Triage strategy (ACUITY) trial. Lancet 369:907–919PubMedCrossRef

22.

Weitz JI, Bates SM (2002) Acute coronary syndromes: a focus on thrombin. J Invasive Cardiol 14(Suppl B):2B–7BPubMed

23.

Young G, Tarantino MD, Wohrley J, Weber LC, Belvedere M, Nugent DJ (2007) Pilot dose-finding and safety study of bivalirudin in infants <6 months of age with thrombosis. J Thromb Haemost 5:1654–1659PubMedCrossRef

Title: Successful Use of Bivalirudin for Superior Vena Cava Recanalization and Stent Placement in a Child with Heparin-Induced Thrombocytopenia
Authors: John P. Breinholt
Brady S. Moffett
Karen M. Texter
Frank F. Ing
Publication date: 01-07-2008
Publisher: Springer-Verlag
Published in: Pediatric Cardiology / Issue 4/2008
Print ISSN: 0172-0643
Electronic ISSN: 1432-1971
DOI: https://doi.org/10.1007/s00246-008-9231-2

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Successful Use of Bivalirudin for Superior Vena Cava Recanalization and Stent Placement in a Child with Heparin-Induced Thrombocytopenia

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2008

Increased Natriuretic Peptide Type B Level After the Second Palliative Step in Children with Univentricular Hearts with Right Ventricular Morphology But Not Left Ventricular Morphology

Mixed Supra- and Infradiaphragmatic Totally Anomalous Pulmonary Venous Connection in an Adolescent

Serial Plasma BNP Levels in Assessing Inadequate Left Ventricular Decompression on ECMO

Tissue Doppler-Derived Diastolic Myocardial Velocities Are Abnormal in Pediatric Cardiac Transplant Recipients in the Absence of Endomyocardial Rejection

Mediastinal Hemangioma and Accompanying Aortic Arch Anomaly

Patient-Activated Antitachycardia Pacing to Terminate Atrial Tachycardias with 1:1 Atrioventricular Conduction in Congenital Heart Disease

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page